Idiopathic Multicentric Castleman Disease Presenting With Hypertensive Choroidopathy: A Case Report

被引:0
|
作者
Mimoto, Tamami [1 ]
Hashida, Noriyasu [1 ,2 ]
Nishida, Kohji [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Ophthalmol, Suita, Japan
[2] Osaka Univ, Ophthalmol, Suita, Japan
关键词
case report; optical coherence tomography; malignant hypertension; choroid; castleman disease;
D O I
10.7759/cureus.33368
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Castleman disease (CD) is a lymphoproliferative disorder and rarely affects ocular tissue. This study aimed to report a case of hypertensive choroidopathy in a patient with Castleman's disease associated with malignant hypertension. A 39-year-old man visited his local physician with fever, systemic edema, and multiple lymphadenopathies. An inguinal lymph node biopsy indicated CD. One month after the biopsy, the patient noted a blurring of vision. At the time of the initial examination at our hospital, his best-corrected visual acuity (BCVA) was 20/20 in both eyes but there were bilateral multiple Elschnig spots and sprinter hemorrhage at the fundus. Swept-source optical coherence tomography showed intra-retinal fluid, and serous retinal detachment (SRD). Fluorescein angiography revealed multiple punctate hyper fluorescences and indocyanine green angiography showed choroidopathy with increased vascular permeability. A general examination revealed symptoms of cardiac failure and multiple lymphadenopathies. Malignant hypertension with acute glomerulonephritis was diagnosed after a renal biopsy. After antihypertensive treatment, his blood pressure (BP) improved, and the SRD and choroidopathy promptly resolved. Presently, the patient is being followed up without complications. We report a case of hypertensive choroidopathy in a patient with CD associated with malignant hypertension. As a severe elevation in BP can damage choroidal vasculature and lead to vision loss, careful observation and active treatment are necessary.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Idiopathic Multicentric Castleman Disease with Cutaneous Manifestation: Case Report
    Kosmidis, Christoforos S.
    Mystakidou, Chrysi Maria
    Koimtzis, Georgios
    Papadopoulou, Evanthia
    Theodorou, Vasiliki
    Katsios, Nikolaos Iason
    Georgakoudi, Eleni
    Sevva, Christina
    Charalampous, Ioannis
    Varsamis, Nikolaos
    Koulouris, Charilaos
    Michael, Christina
    Papadopoulos, Konstantinos
    Anthimidis, Georgios
    Baka, Sofia
    [J]. MEDICINA-LITHUANIA, 2022, 58 (09):
  • [2] Hypertensive choroidopathy in Castleman's disease
    David T. L. Liu
    Jerry A. Shields
    C. L. Li
    H. K. Ng
    Dennis S. C. Lam
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2011, 249 : 1901 - 1903
  • [3] Hypertensive choroidopathy in Castleman's disease
    Liu, David T. L.
    Shields, Jerry A.
    Li, C. L.
    Ng, H. K.
    Lam, Dennis S. C.
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 249 (12) : 1901 - 1903
  • [4] Idiopathic multicentric Castleman's disease with TAFRO syndrome: a case report
    Khan, A., I
    Khan, A.
    Hanan, A.
    Geetha, S.
    Sticco, K.
    Sheikh-Fayyaz, S.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S78 - S78
  • [5] Daratumumab for the treatment of refractory idiopathic multicentric Castleman disease: a case report
    Yujie Shi
    Jian Li
    Lu Zhang
    [J]. Annals of Hematology, 2022, 101 : 2529 - 2531
  • [6] Idiopathic multicentric Castleman's disease with TAFRO syndrome: a case report
    Khan, A. I.
    Khan, A.
    Hanan, A.
    Geetha, S.
    Sticco, K.
    Sheikh-Fayyaz, S.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S78 - S78
  • [7] Daratumumab for the treatment of refractory idiopathic multicentric Castleman disease: a case report
    Shi, Yujie
    Li, Jian
    Zhang, Lu
    [J]. ANNALS OF HEMATOLOGY, 2022, 101 (11) : 2529 - 2531
  • [8] Ruxolitinib for the Treatment of Refractory Idiopathic Multicentric Castleman Disease: A Case Report
    Gao, Yu-Han
    Duan, Ming-Hui
    Li, Jian
    Zhang, Lu
    [J]. TURKISH JOURNAL OF HEMATOLOGY, 2024, 41 (01) : 61 - 63
  • [9] Idiopathic multicentric Castleman disease treated with siltuximab for 15 years: a case report
    Lang, Evan
    Sande, Brenda
    Brodkin, Samantha
    van Rhee, Frits
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [10] MULTICENTRIC CASTLEMAN'S DISEASE: A CASE REPORT
    Gebeyehu, Rediet
    Olatunji-Bello, Temitope
    Tadesse, Aderajew
    Tessema, Admasu
    [J]. ANTICANCER RESEARCH, 2019, 39 (10) : 5843 - 5844